Translational Neural Devices (UG3/UH3- Clinical Trial Optional) (RFA-NS-21-021)

GRANT Saturday, May 1, 2021- 17:30 National Institute of Neurological Disorders and Stroke NINDS intends to commit $4 million to support three to five awards per fiscal year. Multiple dates, see announcement. Translational Neural Devices (UG3/UH3- Clinical Tria

Translational Neural Devices (U44 Clinical Trial Optional) (RFA-NS-21-022)

GRANT Saturday, May 1, 2021- 17:30 National Institute of Neurological Disorders and Stroke The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. NINDS anticipates funding three to five

NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) (RFA-RM-21-018)

GRANT Saturday, May 1, 2021- 17:30 Office of Strategic Coordination (Common Fund) Awards will be for up to $250,000 in direct costs per year, plus applicable Facilities and Administrative (F&A) costs. September 3, 2021 NIH Directors Early Independence Award

Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed) (NOT-MH-21-260)

GRANT Saturday, May 1, 2021- 17:15 National Institutes of Health Estimated total of $95M per year for this FOA and companion U01. Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Cente

Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed) (NOT-MH-21-261)

GRANT Saturday, May 1, 2021- 17:15 National Institutes of Health Estimated total of $95M per year for this FOA and companion UM1. Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collabo

Edward N. and Della L. Thome Memorial Foundation Awards Program in Alzheimer's Disease Drug Discovery Research

GRANT Thursday, April 29, 2021- 08:30 Health Resource in Action June 9, 2021 @ Noon, EDT Edward N. and Della L. Thome Memorial Foundation Awards Program in Alzheimer's Disease Drug Discovery Research

Michelson Prizes: Next-Generation Grants

GRANT Tuesday, April 27, 2021- 09:45 Human Vaccines Project $150,000 June 18, 2021 Michelson Prizes: Next-Generation Grants

NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) (RFA-NS-21-012)

GRANT Saturday, April 24, 2021- 14:45 National Institutes of Health The NIH Blueprint and BRAIN Initiative intend to commit up to $1.1 million per fiscal year to fund approximately 25 awards per year. However, the total amount awarded and the number of awards m

Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Awardees (NOT-CA-21-053)

GRANT Saturday, April 24, 2021- 14:30 National Institutes of Health Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Award

Notice of Pre-Application Webinar for Companion Announcements PAR-21-207 and RFA-AG-22-016 Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent MCI and AD

GRANT Friday, April 16, 2021- 18:00 National Institute on Aging Notice of Pre-Application Webinar for Companion Announcements PAR-21-207 and RFA-AG-22-016 Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairmen

Notice of Intent to Publish the Reissuance of PAR-18-420, NINDS Exploratory Clinical Trials (U01- Clinical Trial Required) (NOT-NS-21-054)

GRANT Saturday, April 10, 2021- 11:30 National Institute of Neurological Disorders and Stroke Notice of Intent to Publish the Reissuance of PAR-18-420, NINDS Exploratory Clinical Trials (U01- Clinical Trial Required) (NOT-NS-21-054)

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) (PAR-21-152)

GRANT Saturday, April 10, 2021- 11:30 National Institute of Neurological Disorders and Stroke Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on t

Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) (PAR-21-207)

GRANT Saturday, April 10, 2021- 11:30 National Institute on Aging NIA intends to commit $2,250,000 in both FY 2022 and FY 2023 to fund four to six awards. Multiple dates, see announcement. Mechanism-Focused Research to Promote Adherence to Healthful Behaviors t

Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required) (RFA-AG-22-016)

GRANT Saturday, April 10, 2021- 11:30 National Institute on Aging NIA intends to commit $3 million in FY 2022 to fund six to eight awards. September 15, 2021 Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impair

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) (RFA-MH-21-180)

GRANT Saturday, April 10, 2021- 11:30 National Institutes of Health Issuing IC and partner components intend to commit an estimated total of $2 million per year to fund two to four awards. Multiple dates, see announcement. BRAIN Initiative: Reagent Resources fo